Skip to main content
SHELTER PHARMA LIMITED logo

SHELTER PHARMA LIMITED — Investor Relations & Filings

Ticker · 543963 ISIN · INE013V01011 BSE.NS Manufacturing
Filings indexed 2 across all filing types
Latest filing 2026-05-13 Regulatory Filings
Country IN India
Listing BSE.NS 543963

About SHELTER PHARMA LIMITED

https://shelter.co.in/

Shelter Pharma Limited specializes in the research, development, and manufacture of Ayurvedic and herbal formulations. The company’s product portfolio is divided into human and veterinary healthcare segments. The human healthcare division focuses on natural remedies for gastrointestinal issues, liver health, skin care, and respiratory conditions, utilizing traditional botanical ingredients. In the veterinary sector, the company provides herbal supplements aimed at enhancing livestock productivity, including growth promoters and lactation stimulants. Shelter Pharma integrates traditional Ayurvedic knowledge with contemporary manufacturing processes to produce standardized herbal medicines in various dosage forms such as tablets, syrups, and topicals. The company prioritizes the development of side-effect-free, natural alternatives to synthetic pharmaceuticals, targeting diverse therapeutic areas for both domestic and international markets.

Recent filings

Filing Released Lang Actions
Intimation under Regulation 30 for Successfully Conducted a CME Programme in Patna Bihar on 11th May 2026
Regulatory Filings Classification · 83% confidence The document is an intimation filed under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 notifying the stock exchange of a corporate event (a CME program). It is neither a financial report nor a proxy/material for shareholder voting, but a routine regulatory announcement under listing rules. It does not present financial statements or detailed management discussion, so it falls under the general Regulatory Filings category (RNS).
2026-05-13 English
Intimation under Regulation 30 of SEBI (LODR) Regulation, 2015- New Product Launch.
Regulatory Filings Classification · 92% confidence The document is an intimation to the stock exchange under SEBI LODR Regulation 30 regarding a new product launch. It is a material event disclosure, not a financial report, dividend notice, share transaction, management change, or any specialized report. Therefore, it falls under the general Regulatory Filings category (RNS).
2026-05-11 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.